Afficher la couverture 'Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 ``PembroRad'' randomized trial | Bourhis, J.' en grand format
/5

0 avis

Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 ``PembroRad'' randomized trial

Archive ouverte

Bourhis, J. | Sire, C. | Tao, Y. | Martin, L. | Alfonsi, M. | Prevost, J. B. | Rives, M. | Lafond, C. | Tourani, J. M. | Biau, J. | Geoffrois, L. | Coutte, Alexandre | Liem, X. | Vauleon, E. | Drouet, F. | Pechery, A. | Guigay, J. | Wanneveich, M. | Auperin, A. | Sun, X.

Edité par CCSD ; Elsevier -

ESMO Virtual Congress, ELECTR NETWORK, SEP 19-OCT 18, 2020. International audience

Consulter en ligne

Suggestions

Du même auteur

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial

Archive ouverte | Tao, Y. | CCSD

International audience. To evaluate potential synergistic effect of pembrolizumab with radiotherapy (RT) compared with a standard-of-care (SOC) cetuximab-RT in patients with locally advanced-squamous cell carcinoma ...

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial

Archive ouverte | Tao, Y. | CCSD

International audience

Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Safety phase of randomized trial GORTEC 2017-01 (REACH)

Archive ouverte | Tao, Y. | CCSD

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, SEP 27-OCT 01, 2019. International audience

Chargement des enrichissements...